Converging or Crossing Curves: Untie the Gordian Knot or Cut it? Appropriate Statistics for Non-Proportional Hazards in Decitabine DACO-016 Study (AML)Jörg Tomeczkowski, Christoph Tapprich, Joris Diels et al.|Advances in Therapy|2015Cited by 11
Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III TrialJörg Tomeczkowski, Christoph Tapprich, Andreas Güntert et al.|Value in Health|2013Cited by 0